Clinical trial
Gen2 Cardiac Ablation System Isthmus-Dependent Atrial Flutter Study
NCT00606463 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Gen2 Cardiac Ablation System Isthmus-Dependent Atrial Flutter Study
- Lead sponsor
- Abbott Medical Devices
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- February 29, 2008
- Completion date
- January 31, 2009
- Enrollment
- 30 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.